Global ADC Platform Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250387

Publication Date:

June 17, 2025

Pages:

124

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global ADC Platform market size is predicted to grow from US$ 6563 million in 2025 to US$ 19210 million in 2031; it is expected to grow at a CAGR of 19.6% from 2025 to 2031.
The ADC platform is designed to generate ADCs with superior safety profiles, sustainable payload delivery and release in tumors, and efficient bystander killing of antigen-low and negative cells.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淎DC Platform Industry Forecast鈥� looks at past sales and reviews total world ADC Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected ADC Platform sales for 2025 through 2031. With ADC Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ADC Platform industry.
This Insight Report provides a comprehensive analysis of the global ADC Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ADC Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global ADC Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ADC Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ADC Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of ADC Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Software Platform
Serve
Segmentation by Application:
Oncology
BioPharmaceuticals
Rare Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nerviano Medical Sciences
Creative Biolabs
Citrix Systems
AstraZeneca
Mersana
Seagen
ADC Therapeutics
Biocytogen
Heidelberg Pharma AG
Sutro
Synaffix
Genovis Group
Adcendo
WuXi Discovery Services
Daiichi Sankyo
Lonza
LEPU BIOPHARMA
HUABO BIOPHARMA
WuXi Biologics

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ADC Platform Market Size (2020-2031)
2.1.2 ADC Platform Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for ADC Platform by Country/Region (2020, 2024 & 2031)
2.2 ADC Platform Segment by Type
2.2.1 Software Platform
2.2.2 Serve
2.3 ADC Platform Market Size by Type
2.3.1 ADC Platform Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global ADC Platform Market Size Market Share by Type (2020-2025)
2.4 ADC Platform Segment by Application
2.4.1 Oncology
2.4.2 BioPharmaceuticals
2.4.3 Rare Disease
2.5 ADC Platform Market Size by Application
2.5.1 ADC Platform Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global ADC Platform Market Size Market Share by Application (2020-2025)
3 ADC Platform Market Size by Player
3.1 ADC Platform Market Size Market Share by Player
3.1.1 Global ADC Platform Revenue by Player (2020-2025)
3.1.2 Global ADC Platform Revenue Market Share by Player (2020-2025)
3.2 Global ADC Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADC Platform by Region
4.1 ADC Platform Market Size by Region (2020-2025)
4.2 Global ADC Platform Annual Revenue by Country/Region (2020-2025)
4.3 Americas ADC Platform Market Size Growth (2020-2025)
4.4 APAC ADC Platform Market Size Growth (2020-2025)
4.5 Europe ADC Platform Market Size Growth (2020-2025)
4.6 Middle East & Africa ADC Platform Market Size Growth (2020-2025)
5 Americas
5.1 Americas ADC Platform Market Size by Country (2020-2025)
5.2 Americas ADC Platform Market Size by Type (2020-2025)
5.3 Americas ADC Platform Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ADC Platform Market Size by Region (2020-2025)
6.2 APAC ADC Platform Market Size by Type (2020-2025)
6.3 APAC ADC Platform Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe ADC Platform Market Size by Country (2020-2025)
7.2 Europe ADC Platform Market Size by Type (2020-2025)
7.3 Europe ADC Platform Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ADC Platform by Region (2020-2025)
8.2 Middle East & Africa ADC Platform Market Size by Type (2020-2025)
8.3 Middle East & Africa ADC Platform Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global ADC Platform Market Forecast
10.1 Global ADC Platform Forecast by Region (2026-2031)
10.1.1 Global ADC Platform Forecast by Region (2026-2031)
10.1.2 Americas ADC Platform Forecast
10.1.3 APAC ADC Platform Forecast
10.1.4 Europe ADC Platform Forecast
10.1.5 Middle East & Africa ADC Platform Forecast
10.2 Americas ADC Platform Forecast by Country (2026-2031)
10.2.1 United States Market ADC Platform Forecast
10.2.2 Canada Market ADC Platform Forecast
10.2.3 Mexico Market ADC Platform Forecast
10.2.4 Brazil Market ADC Platform Forecast
10.3 APAC ADC Platform Forecast by Region (2026-2031)
10.3.1 China ADC Platform Market Forecast
10.3.2 Japan Market ADC Platform Forecast
10.3.3 Korea Market ADC Platform Forecast
10.3.4 Southeast Asia Market ADC Platform Forecast
10.3.5 India Market ADC Platform Forecast
10.3.6 Australia Market ADC Platform Forecast
10.4 Europe ADC Platform Forecast by Country (2026-2031)
10.4.1 Germany Market ADC Platform Forecast
10.4.2 France Market ADC Platform Forecast
10.4.3 UK Market ADC Platform Forecast
10.4.4 Italy Market ADC Platform Forecast
10.4.5 Russia Market ADC Platform Forecast
10.5 Middle East & Africa ADC Platform Forecast by Region (2026-2031)
10.5.1 Egypt Market ADC Platform Forecast
10.5.2 South Africa Market ADC Platform Forecast
10.5.3 Israel Market ADC Platform Forecast
10.5.4 Turkey Market ADC Platform Forecast
10.6 Global ADC Platform Forecast by Type (2026-2031)
10.7 Global ADC Platform Forecast by Application (2026-2031)
10.7.1 GCC Countries Market ADC Platform Forecast
11 Key Players Analysis
11.1 Nerviano Medical Sciences
11.1.1 Nerviano Medical Sciences Company Information
11.1.2 Nerviano Medical Sciences ADC Platform Product Offered
11.1.3 Nerviano Medical Sciences ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Nerviano Medical Sciences Main Business Overview
11.1.5 Nerviano Medical Sciences Latest Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Information
11.2.2 Creative Biolabs ADC Platform Product Offered
11.2.3 Creative Biolabs ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Creative Biolabs Main Business Overview
11.2.5 Creative Biolabs Latest Developments
11.3 Citrix Systems
11.3.1 Citrix Systems Company Information
11.3.2 Citrix Systems ADC Platform Product Offered
11.3.3 Citrix Systems ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Citrix Systems Main Business Overview
11.3.5 Citrix Systems Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca ADC Platform Product Offered
11.4.3 AstraZeneca ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Mersana
11.5.1 Mersana Company Information
11.5.2 Mersana ADC Platform Product Offered
11.5.3 Mersana ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Mersana Main Business Overview
11.5.5 Mersana Latest Developments
11.6 Seagen
11.6.1 Seagen Company Information
11.6.2 Seagen ADC Platform Product Offered
11.6.3 Seagen ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Seagen Main Business Overview
11.6.5 Seagen Latest Developments
11.7 ADC Therapeutics
11.7.1 ADC Therapeutics Company Information
11.7.2 ADC Therapeutics ADC Platform Product Offered
11.7.3 ADC Therapeutics ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 ADC Therapeutics Main Business Overview
11.7.5 ADC Therapeutics Latest Developments
11.8 Biocytogen
11.8.1 Biocytogen Company Information
11.8.2 Biocytogen ADC Platform Product Offered
11.8.3 Biocytogen ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Biocytogen Main Business Overview
11.8.5 Biocytogen Latest Developments
11.9 Heidelberg Pharma AG
11.9.1 Heidelberg Pharma AG Company Information
11.9.2 Heidelberg Pharma AG ADC Platform Product Offered
11.9.3 Heidelberg Pharma AG ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Heidelberg Pharma AG Main Business Overview
11.9.5 Heidelberg Pharma AG Latest Developments
11.10 Sutro
11.10.1 Sutro Company Information
11.10.2 Sutro ADC Platform Product Offered
11.10.3 Sutro ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sutro Main Business Overview
11.10.5 Sutro Latest Developments
11.11 Synaffix
11.11.1 Synaffix Company Information
11.11.2 Synaffix ADC Platform Product Offered
11.11.3 Synaffix ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Synaffix Main Business Overview
11.11.5 Synaffix Latest Developments
11.12 Genovis Group
11.12.1 Genovis Group Company Information
11.12.2 Genovis Group ADC Platform Product Offered
11.12.3 Genovis Group ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Genovis Group Main Business Overview
11.12.5 Genovis Group Latest Developments
11.13 Adcendo
11.13.1 Adcendo Company Information
11.13.2 Adcendo ADC Platform Product Offered
11.13.3 Adcendo ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Adcendo Main Business Overview
11.13.5 Adcendo Latest Developments
11.14 WuXi Discovery Services
11.14.1 WuXi Discovery Services Company Information
11.14.2 WuXi Discovery Services ADC Platform Product Offered
11.14.3 WuXi Discovery Services ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 WuXi Discovery Services Main Business Overview
11.14.5 WuXi Discovery Services Latest Developments
11.15 Daiichi Sankyo
11.15.1 Daiichi Sankyo Company Information
11.15.2 Daiichi Sankyo ADC Platform Product Offered
11.15.3 Daiichi Sankyo ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Daiichi Sankyo Main Business Overview
11.15.5 Daiichi Sankyo Latest Developments
11.16 Lonza
11.16.1 Lonza Company Information
11.16.2 Lonza ADC Platform Product Offered
11.16.3 Lonza ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Lonza Main Business Overview
11.16.5 Lonza Latest Developments
11.17 LEPU BIOPHARMA
11.17.1 LEPU BIOPHARMA Company Information
11.17.2 LEPU BIOPHARMA ADC Platform Product Offered
11.17.3 LEPU BIOPHARMA ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 LEPU BIOPHARMA Main Business Overview
11.17.5 LEPU BIOPHARMA Latest Developments
11.18 HUABO BIOPHARMA
11.18.1 HUABO BIOPHARMA Company Information
11.18.2 HUABO BIOPHARMA ADC Platform Product Offered
11.18.3 HUABO BIOPHARMA ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 HUABO BIOPHARMA Main Business Overview
11.18.5 HUABO BIOPHARMA Latest Developments
11.19 WuXi Biologics
11.19.1 WuXi Biologics Company Information
11.19.2 WuXi Biologics ADC Platform Product Offered
11.19.3 WuXi Biologics ADC Platform Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 WuXi Biologics Main Business Overview
11.19.5 WuXi Biologics Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂